- Di sistema
- Emerging strategies are moving towards personalized medicine, with molecular profiling guiding treatment choices. New immunotherapies, such as car-t cell therapy and tumor-infiltrating lymphocyte (til) therapy, are in development, alongside novel targeted therapies like kras inhibitors. Advances in radiation, including adaptive and flash radiotherapy, are improving precision and outcomes. Liquid biopsies are emerging as a tool for early detection and monitoring, while cancer vaccines and artificial intelligence are being explored for more effective treatment planning and personalized approaches. Together, these strategies are shaping a future of more tailored, effective treatments for thoracic cancers.
The event will explore these topics in depth to provide participants with up-to-date information useful for more efficient management and care of patients with thoracic cancers.